Drugs & Targets Merck will withdraw Keytruda’s “dangling” indication for gastric cancer July 09, 2021Vol.47 No.27
In Brief Marcus Bosenberg named inaugural director of Yale Center for Immuno-Oncology July 02, 2021Vol.47 No.26
In Brief Sarah Tasian named chief of the Section of Hematologic Malignancies at CHOP July 02, 2021Vol.47 No.26
In Brief AccessHope, Dana-Farber Cancer Institute partner to expand access to specialized cancer treatments July 02, 2021Vol.47 No.26
Clinical Roundup Study sheds light on persistent racial disparities in prostate cancer care in the U.S. July 02, 2021Vol.47 No.26
Clinical Roundup City of Hope-led research identifies how the most common type of breast cancer becomes resistant to treatment July 02, 2021Vol.47 No.26
Clinical Roundup USC cancer neuroscientists identify a key culprit behind pediatric brain cancer’s spread July 02, 2021Vol.47 No.26
Drugs & Targets Rylaze receives FDA approval as component of chemotherapy regimen for leukemia and lymphoma July 02, 2021Vol.47 No.26
